Showing results (1651-1660 of 1,724) with videos related to

Sort By:
Pageof 173
Antibiotics (Basel, Switzerland)|December 30, 2025
Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: Initial In Vivo Proof-of-ConceptF Ruben H A Nurmohamed, Kevin J H Allen, Mackenzie E Malo, et al.
Nature Communications|March 14, 2025
Structure-guided design of partial agonists at an opioid receptorBalazs R Varga, Sarah M Bernhard, Amal El Daibani, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 3, 2016
Antiangiogenic activity of 2-formyl-8-hydroxy-quinolinium chlorideK-H Lam, K K-H Lee, S H-L Kok, et al.
Journal of the American College of Cardiology|October 7, 2017
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection FractionPhillip H Lam, Daniel J Dooley, Prakash Deedwania, et al.
European Journal of Heart Failure|October 6, 2017
Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trialPhillip H Lam, Daniel J Dooley, Gregg C Fonarow, et al.
Free Radical Biology & Medicine|October 27, 2009
Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type miceSergio Rodriguez-Cuenca, Helena M Cochemé, Angela Logan, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 22, 2018
Recommendations on prevention and screening for breast cancer in Hong KongT H Lam, K H Wong, K Kl Chan, et al.
Cell Metabolism|April 23, 2024
Loss of GPR75 protects against non-alcoholic fatty liver disease and body fat accumulationAlasdair Leeson-Payne, Jean Iyinikkel, Cameron Malcolm, et al.
Breast Cancer Research and Treatment|June 8, 2015
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patientsLisette Binkhorst, Jacqueline S L Kloth, Annelieke S de Wit, et al.
Pageof 173